Press Releases

Researchers at Roswell Park Comprehensive Cancer Center, working in collaboration with Genome Protection, Inc. and Children’s Cancer Institute in Sydney, Australia, have discovered a novel way by which highly repetitive genetic components belonging to the LINE-1 family of retrotransposons enable tumors to escape treatment. The study demonstrates that LINE-1 activation can promote treatment resistance by inducing inflammatory pathways. Importantly, existing antiviral drugs overcame this resistance in preclinical cancer models.

Faced with extremely low rates of lung cancer screening and poor access to early detection services in some communities, Roswell Park Comprehensive Cancer Center worked with state and local officials to tackle the challenge of reducing lung cancer’s impact on Western New York. The result of this collaboration is Eddy, or Early Detection Driven to You — lung cancer screening on wheels, implemented through novel outreach programs targeted to benefit underserved and high-risk communities.

Researchers from Roswell Park Comprehensive Cancer Center, in collaboration with Gero and Genome Protection Inc., recently published new work in Nature Communications that demonstrates the power of artificial intelligence (AI) combined with analytical tools borrowed from the physics of complex systems to provide insights into the nature of aging, resilience, and future medical interventions for age-related diseases including cancer.

Roswell Park Comprehensive Cancer Center is soon to welcome its newest culinary option, Joe’s Deli, to campus. The Buffalo-based delicatessen will offer signature fresh foods and smoothies in a café space in the Scott Bieler Clinical Sciences Center on the cancer center’s main campus.

In recognition of its efforts to promote diversity in nursing career development and reduce healthcare disparities, Roswell Park Comprehensive Cancer Center has received the 2022 Partnership of the Year Award from Buffalo Black Nurses Inc.

A targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates when tested in a large multicenter clinical trial conducted by the Children’s Oncology Group (COG) co-led by Roswell Park's Kara Kelly, MD. The study results have been reported in the New England Journal of Medicine.

Lung cancer is the leading cause of cancer death in the United States, accounting for almost 25% of all cancer deaths. Roswell Park is one of more than 50 organizations calling for greater awareness to get eligible people screened.

Roswell Park is proud to break ground on a new Community Outreach & Engagement Building at 907 Michigan Avenue in Buffalo. The project, which includes preservation of a home in Buffalo’s historic Fruit Belt neighborhood, will be the new hub for the cancer center’s extensive Community Outreach and Engagement (COE) team.

Recognized for her “extraordinary work and incredible spirit,” Roswell Park Comprehensive Cancer Center President & CEO Candace S. Johnson, PhD, was named an Advocacy in Action Award winner by Western New York’s Housing Opportunities Made Equal (HOME, Inc.).